Research  >  Labs & groups  >  Bulbar function laboratory
Share:  
|
PAGE
MENU

Scientist profiles S-Z

SRI Profiles

Lorne Zinman, MD, MSc, FRCPC

Associate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room UG 26
Toronto, ON
M4N 3M5

Phone: 416-480-4213
Fax: 416-480-6817

Administrative Assistant: Olive Grozelle
Phone: 416-480-4213
Email: olive.grozelle@sunnybrook.ca

Education:

  • M.Sc., 1993, biology/physiology, University of Toronto, Canada
  • M.Sc., 1995, neurobiology, Queen’s University, Canada
  • MD, 1998, University of Calgary, Canada
  • FRCPC, 2003, neurology, U of T, Canada
  • M.Sc., 2005, clinical epidemiology, U of T, Canada

Appointments and Affiliations:

  • Associate scientist, Evaluative Clinical SciencesHurvitz Brain Sciences Research Program, Sunnybrook Research Institute
  • Staff neurologist, Sunnybrook Health Sciences Centre
  • Director, electromyogram laboratory, Sunnybrook
  • Associate professor, medicine (neurology), U of T
  • Director, amyotrophic lateral sclerosis (ALS) and neuromuscular clinic
  • Chair, Canadian ALS Research Network

Research Focus:

  • ALS and neuromuscular diseases

Research Summary:

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating neurological disease that results in the degeneration of motor neurons leading to paralysis and death in most patients. There is no treatment to halt or reverse ALS and the specific cause remains unknown. Dr. Zinman’s research aims to characterize better the clinical, electrophysiological and pathological phenotypes and variants of the disease to find a treatment.

In collaboration with Drs. Janice Robertson, Ekaterina Rogaeva, Yana Yunusova and Julia Keith, the group continues to study the disease’s pathophysiology to discover novel therapeutic targets. Epidemiological research provides clues to the etiology and exacerbating factors of the disease. The team also leads and participates in multicentre clinical trials evaluating the most promising ALS therapeutics.

Research interests include conducting clinical trials and investigating the neurophysiological and epidemiological features of neuromuscular diseases such as myasthenia gravis, Guillain-Barré syndrome and other immune-mediated neuropathies.

Selected Publications:

See current publications list at PubMed.

Related News and Stories:

Related Links: